跳转至内容
Merck
CN

790326P

Avanti

荧光转染试剂

Avanti Research - A Croda Brand

别名:

荧光转染试剂, 荧光转染试剂,含有 DOTAP:DOPE (1:1, w/w) + 0.1 wt.% NBD-DOPE

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352211
NACRES:
NA.83
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

荧光转染试剂, Avanti Research - A Croda Brand, powder

assay

>99% (TLC)

form

powder

packaging

pkg of 1 × 10 mg (790326P-10mg)

technique(s)

transfection: suitable

lipid type

transfection
cationic lipids

shipped in

dry ice

storage temp.

−20°C

manufacturer/tradename

Avanti Research - A Croda Brand

正在寻找类似产品? 访问 产品对比指南

Biochem/physiol Actions

DOTAP:DOPE 与 0.1% NBD-DOPE 脂质体(LipNBD)用转铁蛋白重组,称为转铁蛋白脂质体-硝基苯并恶二唑(Tf-LipNBD),可用作探针。它在肿瘤细胞的体外磁共振成像(MRI) 中提供了改进的图像对比度。荧光转染试剂有助于了解纤维复合物膜结构和丝心蛋白与阳离子脂质的相互作用。N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)dioleoyl(NBD) 用于模型膜研究,可用于可视化膜域。

General description

荧光转染试剂具有比例为 1:1 的阳离子脂质 1,2-二油酰氧基丙基)-N,N,N-三甲基氯化铵(DOTAP)和中性脂质 DOPE(1,2-二油酰-sn-甘油-3-磷酸乙醇胺) w/w 以及 0.1 wt% N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)dioleoyl (NBD) DOPE。NBD-DOPE 是一种荧光探针,NBD 连接到 DOPE 的头部。

Packaging

5 mL透明玻璃密封安瓿(790326P-10mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Application

Transfection research

存储类别

11 - Combustible Solids

flash_point_f

No data available

flash_point_c

No data available


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

The influence of NBD fluorescent probe on model membranes containing POPC and DPPC
Weng CJ, et al.
Molecular Membrane Biology, 33(1-2), 23-28 (2016)
Efficiency data of intracellular recombinant protein delivery using cationic lipid coated silk fibroin particle
Kim WJ, et al.
Data in Brief, 13, 683-691 (2017)
Dual probe with fluorescent and magnetic properties for imaging solid tumor xenografts
Shan L, et al.
Molecular Imaging, 6(2), 7290-2007 (2007)
Woo-Jin Kim et al.
Biomaterials, 122, 154-162 (2017-01-26)
Directly delivering therapeutic proteins into cells has promise as an intervention without side effects for protein deficiencies caused by genetic defects. However, as negatively charged macromolecules, proteins require carriers for achieving cellular uptake and maintaining their activity in the cytoplasm.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持